<DOC>
	<DOCNO>NCT00979420</DOCNO>
	<brief_summary>The question prompt study extent result clinical trial translate everyday practice ( external validity ) . An observation period 10 year extend far beyond duration clinical trial . First foremost question tolerability efficacy antiretroviral combination treatment Viramune antiretroviral partner . In particular , adverse event record therapeutic effect monitor via course viral load improvement immune system , base CD4 cell count .</brief_summary>
	<brief_title>Non-interventional Observational Study With Viramune ( Nevirapine ) Various Drug Combinations Antiretroviral Combination Treatment HIV-infected Patients Who Have Already Been Treated Approx . 10 Years With Viramune</brief_title>
	<detailed_description>Study Design : observational</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Inclusion criterion The inclusion criterion treatment Viramune plus antiretroviral combination drug base current Information Healthcare Professionals/SPC ( R080843 ) Exclusion criteria The exclusion criterion treatment Viramune plus antiretroviral combination drug base current Information Healthcare Professionals/SPC ( R080843 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>treatment experience</keyword>
</DOC>